Počet záznamov: 1
HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway
SYS 0179507 LBL 00000naa--2200000-a-4500 005 20250607174429.7 008 220307s2021----xo-----e------------eng-- 040 $a BA006 $b slo 041 0-
$a eng $b eng 044 $a xo $c SK 245 10
$a HDAC3-mediated lncRNA-LOC101928316 contributes to cisplatin resistance in gastric cancer via activating the PI3K-Akt-mTOR pathway / $c Hengjie Ren, Liyun Tang 300 $b ilustr., aj fareb., grafy, obr. 504 $a Bibliogr. odkazy 504 $a Res. angl. 650 12
$7 sllk_us_auth*d013274 $a nádory žalúdka $2 mesh 650 12
$7 sllk_us_auth*d006655 $a histón deacetylázy $2 mesh 650 22
$7 sllk_us_auth*d062085 $a RNA dlhá nekódujúca $2 mesh 650 22
$7 sllk_us_auth*d004351 $a rezistencia lieková $2 mesh 650 22
$7 sllk_us_auth*d002945 $a cisplatina $2 mesh 650 22
$7 sllk_us_auth*d009385 $a procesy nádorové $2 mesh 650 22
$7 sllk_us_auth*d045744 $a línia bunková nádorová $2 mesh 653 2-
$a histón deacetyláza 3 653 2-
$a expresia HDAC3 653 2-
$a expresia lncRNA LOC101928316 653 2-
$a štúdia experimentálna 700 1-
$7 sllk_us_auth*0055572 $a Ren, Hengjie $4 aut 773 0-
$7 nnas $w sllk_us_cat*0179326 $t Neoplasma $f Cancer Research Institute of the Slovak Academy of Sciences $x 0028-2685 $d Bratislava : AEPress, 2021 $g Vol. 68, no. 5 (2021), s. 1043-1051
Počet záznamov: 1